Skip Navigation
Plans and Priorities for Cancer Research NCI Home 2003 Plans and Priorities for Cancer Research  Plans and Priorities Home Sitemap FAQ PDF
Director’s message

Executive summary

Highlights of progress

2003 Budget Request

Scientific Priorities for Cancer Research— Extraordinary Opportunities

Infrastructure Needed for Cancer Research — NCI’s Challenge

About NCI

Planning National Agendas in Disease-Specific Research

Additional Cancer Information for Patients and Health Professionals





The 2003 NCI Budget Request

printer Print this page
envelope Email this page
dictionary Define terms on this page

Footnotes to Historical Budget Information

Footnote
Number
Description
1. Includes $18,163,000 for training funds provided by Continuing Resolution.
2. Includes $3,201,000 for training funds provided by Continuing Resolution.
3. Includes $20,129,000 for training funds provided by Continuing Resolution.
4. Authorized under a Continuing Resolution.
5. Reflects rescission of $11,975,000.
6. Continuing Resolution. Includes $47,988 transferred to National Institute of Environmental Health Sciences for National Toxicology Program.
7. Continuing Resolution and Supplemental Appropriation Bill
8. Includes $23,861,000 for training funds provided by a Continuing Resolution and $4,278,000 in a Supplemental Appropriation Bill.
9. Includes $6,000,000 from a Supplemental Appropriation Bill.
10. Omnibus Continuing Resolution.
11. Omnibus Continuing Resolution.
12. Prior to reductions in GP 517 (-$19,122.000) and GP 215 (-$2,535,000) and PL 100-436, Section 213, (-$1,013,000).
13. Prior to reductions in PL 101-166 (-$6,839,000) and PL 101-239 ($22,829,000)
14. Prior to reduction in PL 101-517 ($8,972,000 for salary and expense reduction; -$42,568,000 for across-the-board reduction.)
15. Prior to reduction in PL 102-170 (-$21,475,000 for salary and expense reduction; $1,262,000 for travel reduction; $15,000,000 transferred to other institutes for cancer research).
16. Prior to reductions in PL 102-294 (-$16,060,000 for .8% reduction to all line items, -9,933,000 for S&E reduction, -139,000 for consultant services reduction).
17. Prior to reduction in PL 103-211 (-$5,885,000 administration reduction).
18. Prior to reduction in PL 103-211 (-$1,883,000 for Procurement reduction; -$116,000 for SLUC reduction; -$1,052,000 for Bonus Pay reduction). Includes $218,199,000 of AIDS funding.
19. Includes $225,790,000 of AIDS funding.
20. Includes $224,983,000 of AIDS funding.
21. Prior to reductions in PL 105-119 (-$4,755,000 via the Secretary's 1% transfer authority). Includes $8,699,000 transferred via the NIH Director's 1% transfer authority, $41,000 transfer from U.S. Dept of State in PL 105-119, and $226,414,000 of AIDS funding.
22. Prior to reductions in PL 106-51 (-$1,940,000 for travel and admin expenses). Includes -931,000 transferred via the Secretary's 1% transfer authority, and -$6,259,000 transferred via the NIH Director's 1% transfer authority, and $239,190,000 of AIDS funding.
23. Appropriation prior to reductions in PL 106-113 (-$17,763,000 for across the board reduction). Includes $245,804,000 of AIDS funding.

Back to Historical Budget Page



Home | Site Map | FAQs | PDF | Privacy Policy | Accessibility | Contact Us

Last updated 02.13.02 (smz)
W3C Validated

Other U.S. Government Resources

National Institutes of HeALT (NIH)


Department of HeALT and Human Services


FirstGov